Russell Investments Group
ADMA icon

Russell Investments Group’s ADMA Biologics ADMA Stock Holding History

Russell Investments Group’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.09M Buy
727,880
+16,187
+2% +$148K 0.01% 1385
2026
Q1 		$6.41M Sell
711,693
-344,639
-33% -$5.44M 0.01% 1206
2025
Q4 		$19.3M Sell
1,056,332
-181,092
-15% -$3.05M 0.02% 646
2025
Q3 		$18.1M Sell
1,237,424
-582,086
-32% -$9.98M 0.02% 657
2025
Q2 		$33.1M Buy
1,819,510
+186,835
+11% +$3.81M 0.04% 430
2025
Q1 		$32.4M Buy
1,632,675
+986,666
+153% +$17.1M 0.04% 432
2024
Q4 		$11.1M Sell
646,009
-162,033
-20% -$3.05M 0.02% 767
2024
Q3 		$16.2M Sell
808,042
-489,172
-38% -$7.61M 0.02% 651
2024
Q2 		$14.5M Buy
1,297,214
+128,007
+11% +$1.07M 0.02% 647
2024
Q1 		$7.72M Buy
1,169,207
+556,175
+91% +$3.04M 0.01% 953
2023
Q4 		$2.77M Buy
613,032
+236,255
+63% +$874K ﹤0.01% 1439
2023
Q3 		$1.35M Buy
376,777
+287,959
+324% +$1.11M ﹤0.01% 1772
2023
Q2 		$328K Buy
88,818
+87,515
+6,716% +$324K ﹤0.01% 2352
2023
Q1 		$4.31K Buy
+1,303
New +$4.5K ﹤0.01% 2955
2021
Q1 		– Sell
-123,968
Closed -$241K – 3086
2020
Q4 		$241K Buy
+123,968
New +$261K ﹤0.01% 2697

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Russell Investments Group's ADMA Position: Q2 2026 in Review

Russell Investments Group increased its ADMA Biologics (ADMA) stake by 2.3% in Q2 2026, buying an estimated $148K and bringing the position to 727,880 shares worth $6.09M. The position accounts for 0.01% of the portfolio, ranked #1385.

Russell Investments Group first reported a position in ADMA in Q4 2020 and has held it in 15 quarters since. The position peaked at $33.1M in Q2 2025. 322 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Russell Investments Group held 727,880 shares of ADMA Biologics worth $6.09M as of Q2 2026.
  • Russell Investments Group bought 16,187 ADMA Biologics shares in Q2 2026, an estimated $148K.
  • ADMA Biologics made up 0.01% of Russell Investments Group's portfolio in Q2 2026, its #1385 holding.
  • Russell Investments Group first reported a position in ADMA Biologics in Q4 2020 and has held it in 15 quarters since.
  • Russell Investments Group's ADMA Biologics position peaked at $33.1M in Q2 2025.
  • 322 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.